Radar Therapeutics
Berkeley · Founded 2022
About Radar Therapeutics
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.4M
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: https://www.radartx.bio/
- Phone: [email protected]
Industries & Categories
Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/radar-therapeutics-106175 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.